Home » News » AMC and Co. – excesses: The New York Stock Exchange is degenerating more and more into a circus

AMC and Co. – excesses: The New York Stock Exchange is degenerating more and more into a circus

Sometimes three-digit percentage daily fluctuations in some US stocks such as AMC. Pricing for the derivatives is even more adventurous. It’s never been like this before. Excesses wherever you look. If that only turns out well …

Arbonia: Board of directors writes put options for 300,000 shares with an exercise price of CHF 17.20. Presumably chairman of the board of directors and company boss Alexander von Witzleben. More on the topic at 12.30 p.m. in my column.

EFG International: UBS goes to BUY (neutral) until 8.70 (5.50) Fr. Impressive cost control meets brisk customer influx. Earnings estimates are increased by up to 16 percent.

AMS: Sells subsidiary Digital Systems to American Acuity Brands. Further area sales are likely to follow, according to dealers.

Burckhardt Compression: Research Partners are disappointed for BUY up to 425 (400) Fr. service business. New year targets seem conservative.

Datwyler: Vontobel increases to CHF 289 (265) with HOLD. Expect higher growth in the future.

Dottikon: ZKB goes to OVERWEIGHT (market weights). Solid operational trends and only minor capacity bottlenecks.

Julius Bär: UBS is for NEUTRAL up to 63 (55) Fr. Late reaction to the interim confession. Profit estimates are increased by up to 26 percent.

Kuehne + Nagel: HSBC goes to 265 (180) Fr. with HOLD.

Landis+Gyr: Credit Suisse defends the share with OUTPERFORM up to CHF 79. Expects to receive larger orders from overseas for smart electricity meters soon.

Logitech: Has made several small company acquisitions since the beginning of the year without disclosing them. Total volume around $ 42 million, as company boss Bracken Darrell reveals to colleagues from L’Agefi. Kepler Cheuvreux stays for BUY up to CHF 120.

Novartis: Reports positive study results on Lutathera.

Phoenix Mecano: Research Partners go to HOLD (Buy) to 530 Fr. Only this year’s earnings estimates are increased.

Swiss Re: Reportedly received $ 314 million in proceeds from the sale of its New China Insurance stake. The proceeds are more generous than originally thought.

Temenos: Announces technology partnership with Chinese Huawei. Kepler Cheuvreux is pleased, is for BUY up to 150 Fr.

Trifork: Today is the first day of trading. Also listed on the Copenhagen Stock Exchange. Issue price at 155 DKr. per share. Arithmetical parity at 22.57 Fr.

Derivatives: Smaller sales in the knock-out puts OSMANV on the SMI as well as ODAAPV and ODABAV on the DAX.

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.